Medicare AdvantageCoverageHigh impact
MA11.001k, Treatment of Varicose Veins of the Lower Extremities and Perforator Vein Incompetence
Independence Blue Cross·PA · Vascular Surgery, General Surgery·Medical Policy
Effective date
Jul 28, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated MA policy MA11.001k to MA11.001l effective 07/28/2025, clarifying TIPP terminology, revising the Venous Clinical Severity Score (VCSS) threshold for saphenous vein treatment from less than 6 to greater than 6, adding CPT 37799 for endovenous cryoablation, and removing experimental/investigational language for certain perforator vein procedures. These changes affect coverage criteria and billing for varicose vein treatments.
Action Required
By 07/28/2025, the billing team must: (1) Update medical necessity documentation requirements to reflect the revised VCSS threshold of greater than 6 (not less than 6) for C2 and C3 disease treatment of great/small saphenous veins—verify all prior authorization templates and billing system rules reflect this change; (2) Add CPT 37799 to the medically necessary code list in the billing system for endovenous cryoablation claims; (3) Remove experimental/investigational exclusion language from billing system rules for ambulatory hook and stab avulsion or TIPP (TriVex system) procedures for perforator, great, or small saphenous or accessory saphenous veins—these are now covered if medical necessity criteria are met; (4) Update provider education materials and encounter documentation templates to clarify that TIPP refers to the TriVex system; (5) Train billing and authorization staff on the new policy to ensure accurate claim submission and denial prevention. Failure to update criteria will result in claim denials for procedures that now meet medical necessity or incorrect VCSS threshold denials.